|
KIAA0368 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.2883999946427E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.85529999830703E-08 |
| Normal-vs-Stage2 |
1.573660E-02 |
| Normal-vs-Stage3 |
1.10860000068769E-08 |
| Normal-vs-Stage4 |
4.68619998361675E-09 |
| Stage1-vs-Stage2 |
1.036980E-01 |
| Stage1-vs-Stage3 |
2.029400E-01 |
| Stage1-vs-Stage4 |
3.096300E-02 |
| Stage2-vs-Stage3 |
3.907700E-02 |
| Stage2-vs-Stage4 |
6.124600E-03 |
| Stage3-vs-Stage4 |
2.512400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.30970001510633E-09 |
| Normal-vs-AfricanAmerican |
4.197200E-03 |
| Normal-vs-Asian |
2.28729999999233E-05 |
| Caucasian-vs-AfricanAmerican |
3.133600E-01 |
| Caucasian-vs-Asian |
6.859400E-01 |
| AfricanAmerican-vs-Asian |
5.130800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90980000036589E-07 |
| Normal-vs-Female |
2.14649999996652E-08 |
| Male-vs-Female |
8.057800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.26929999978121E-07 |
| Normal-vs-Age(41-60Yrs) |
5.21010001808264E-09 |
| Normal-vs-Age(61-80Yrs) |
1.34080000002701E-06 |
| Normal-vs-Age(81-100Yrs) |
1.398690E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.052200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.815000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.312000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.542400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.494600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.064400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.312300E-02 |
| Classical-VS-Follicular |
6.275200E-01 |
| Classical-VS-Other |
2.292400E-01 |
| Classical-VS-Normal |
2.58510000072931E-08 |
| Tall-VS-Follicular |
4.170200E-02 |
| Tall-VS-Other |
8.359600E-01 |
| Tall-VS-Normal |
3.3353999995267E-07 |
| Follicular-VS-Other |
2.751600E-01 |
| Follicular-VS-Normal |
2.963700E-04 |
| Other-VS-Normal |
1.936140E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.69119999963108E-07 |
| Normal-vs-N1 |
2.3534999504804E-09 |
| N0-vs-N1 |
1.080090E-02 |
|
|
